Health CanadaType III
ANTIHISTAMINE ORAL: The affected lot may contain concentrations of Ephedrine Hyd...
Published: December 16, 2024Recall ID: 76709Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
ANTIHISTAMINE ORAL
Additional Source Details
| Field | Value |
|---|---|
| N I D | 76709 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/antihistamine-oral-affected-lot-may-contain-concentrations-ephedrine-hydrochloride-and |
| Issue | Product safety |
| Title | ANTIHISTAMINE ORAL: The affected lot may contain concentrations of Ephedrine Hydrochloride and Pyrilamine Maleate that are outside the labeled concentration. |
| Product | ANTIHISTAMINE ORAL |
| Archived | 0 |
| Category | Veterinary drugs |
| Last updated | 2024-12-16 |
| Organization | Drugs and health products |
| Recall class | Type III |
| What you should do | Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |